Surface Oncology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.40
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.47
|
-0.39
|
0.08
|
17.02%
|
|
2022-06-30
|
-0.46
|
-0.46
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.28
|
0.13
|
0.41
|
146.43%
|
|
2021-12-31
|
-0.15
|
-0.52
|
-0.37
|
-246.67%
|
|
2021-09-30
|
-0.40
|
-0.44
|
-0.04
|
-10.00%
|
|
2021-06-30
|
-0.35
|
-0.44
|
-0.09
|
-25.71%
|
|
2021-03-31
|
-0.41
|
-0.37
|
0.04
|
9.76%
|
|
2020-12-31
|
0.22
|
1.56
|
1.34
|
609.09%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.72
|
|
2021-12-31
|
-1.77
|
|
2020-12-31
|
1.47
|
|
2019-12-31
|
-1.97
|
|
2018-12-31
|
-0.47
|
|
2017-12-31
|
-2.27
|